Early, easy, more effective childhood myopia control
The patented Eyerising Myopia Management Device’s RLRL therapy is designed to be child-friendly, convenient to use at home, and more effective at controlling childhood myopia. The device is non-invasive and has no risk of infection. It can be used with out additional medications, eyedrops, or contact lenses, with no known significant side effects. This makes it suitable and easily tolerated by children as young as 3 and up to 16.
Easy to use myopia control at home
Therapy involves looking into the device for a 3-minute treatment, 2 times per day, 5 days per week, with a minimum of 4 hours between sessions. The device is controlled via a simple touchscreen and monitors patient use. The system also sends reminders to the child’s guardians to maintain patient compliance and maximize treatment efficacy.
Achieving up to 87.7% myopia control efficacy
The device has been proven in published clinical trials to be effective in the treatment of myopia, dramatically slowing its progression by up to 87.7% when the compliance rate is more than 75%1.
1. Jiang, Y., Zhu, Z., Tan, X., Kong, X., Zhong, H., Zhang, J., Xiong, R., Yuan, Y., Zeng, J., Morgan, I. G., & He, M. (2022). Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial. Ophthalmology, 129(5), 509–519. https://doi.org/10.1016/j.ophtha.2021.11.023